{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T09:29:03Z","timestamp":1684229343654},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BLCTT"],"DOI":"10.2147\/blctt.s90764","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:39:36Z","timestamp":1464136776000},"page":"21","source":"Crossref","is-referenced-by-count":1,"title":["Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes"],"prefix":"10.2147","author":[{"given":"Beth","family":"Faiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Valent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,5]]},"container-title":["Blood and Lymphatic Cancer: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=30539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:48:10Z","timestamp":1477867690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/assessment-and-monitoring-of-patients-receiving-chemotherapy-for-multi-peer-reviewed-article-BLCTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/blctt.s90764","relation":{},"ISSN":["1179-9889"],"issn-type":[{"value":"1179-9889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}